Skip to main content
. 2021 Aug 4;22:592. doi: 10.1186/s12864-021-07876-9

Table 5.

Statistics of whole-exome sequencing

SAMPLE Total number of reads Mean Target Coverage % target bases covered at least 10X % target bases covered at least 20X % target bases covered at least 50X % target bases covered at least 100X
357muscle 55,062,491 35.5 88.9% 66.7% 19.6% 3.3%
368muscle 68,408,757 43.6 92.1% 75.1% 28.2% 5.8%
373muscle 125,208,792 69.7 96.1% 88.5% 54.2% 18.3%
358muscle 249,603,786 128.7 98.0% 95.4% 80.1% 49.2%
358N1 52,236,649 33.8 88.1% 64.8% 18.1% 3.0%
357N5 59,870,967 37.5 90.0% 69.5% 22.3% 4.1%
368N8 69,492,339 43.2 91.9% 75.0% 28.6% 6.1%
373N4 92,890,008 55.4 94.0% 82.4% 42.4% 12.2%
368N2 126,289,004 63.6 95.8% 87.2% 50.1% 15.5%
357N1 140,082,301 77.6 96.2% 89.4% 59.0% 23.8%
358N3 144,107,456 78.4 96.5% 90.2% 61.2% 25.2%
373N3 141,719,445 84.8 96.7% 91.0% 64.2% 28.4%
357N4 172,106,294 91.2 97.2% 92.4% 67.3% 31.1%
368N4 207,370,862 110.2 97.9% 94.8% 76.5% 42.3%
358N2 209,306,186 113.7 97.8% 94.5% 76.3% 43.0%
373N1 235,568,319 123.9 97.9% 95.0% 79.0% 47.9%

Statistics about whole-exome sequencing are given. These include the total number of reads, the mean target coverage and the percent of target bases covered at least at 10X, 20X, 50X and 100X for each tumor and muscle tissue sample.